LanteRNA
Gothenburg
About LanteRNA
Stealth Labels Biotech includes nucleic acid label development, nucleic acid microscopy or spectroscopy, and comprehension of medication transport mechanisms. The industrial research center for Functional RNA Delivery developed the technology. They offer next-generation nucleotide pharmaceuticals and medication delivery vehicles.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $552.5K
- Funding stage: Seed
- Last round: Seed (May 2024)
- Website: lanterna.tech
Industries & Categories
Biotechnology, Market Research, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/lanterna-148021 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.